Abstract
The pharmaceutical industry was first licensed to produce acetyl cholinesterase inhibitors (ACIs) in April 1997. The current popularity of this intervention is due to its key aim to treat the symptoms of early to moderate stage dementia. Recent evidence has shown that the therapeutic intervention cognitive stimulation therapy (CST) is comparable to intervention with ACIs. The results of a randomised controlled trial of a CST programme allowed the size of its effects to be compared with published data from trials of the major dementia drugs. This opinion piece directs the spotlight onto CST, describing it and its recent clinical evidence, and asks the question: why have occupational therapists not been more engaged in developing and using such interventions?
Get full access to this article
View all access options for this article.